Year: 2026
Type: article
Abstract: Ferroptosis, a form of cell death induced by overwhelming membrane lipid peroxidation, is a vulnerability of many cancers, including cancers resistant to current molecular and immune-based therapies 1–7 . Triggering of ferroptosis therefore provides an opportunity to achieve elimination of difficult-to-treat cancers 1–4,8,9 . Studies in mouse cancer models have demonstrated that anticancer immunity, mediated by dendritic cells (DCs) and CD8 + T cells, is essential for effective tumour eradication by ferroptosis-inducing strategies 10–13 . However, ferroptotic cells limit this response 8–10,14 , resulting in immune escape and tumour growth through mechanisms that remain unclear. Here we demonstrate that ferroptotic cancer cells activate a molecular program resulting in aberrant production of prostaglandin E 2 (PGE 2 ), which limits the stimulation of anticancer CD8 + T cell responses by type 1 conventional DCs (cDC1s), thereby promoting immune escape. In ferroptotic cancer cells, lipid peroxidation-mediated membrane permeabilization enables Ca 2+ influx, which activates p38 MAPK signalling and thereby drives PGE 2 production. This signalling axis is uncoupled from cancer cell death and can be targeted to selectively interfere with immune-inhibitory PGE 2 production while preserving ferroptotic cancer cell elimination. In the context of cancer cell ferroptosis, ablation of PGE 2 production or disrupting PGE 2 signalling restores cDC1-mediated anticancer CD8 + T cell responses and leads to effective tumour elimination. Our findings identify a key mechanism that limits antitumour immunity and prevents tumour elimination upon ferroptosis induction in cancer cells, which could be exploited for cancer therapy.
Source: Nature
Authors: Lukas Ramsauer, Anna-Marie Pedde, Anna Hirschberger, María Parra Reyes, Nadine Nuschele, Felix Bayerl, Sebastian Lacher, Sainitin Donakonda, Kevin Schmid, Benedikt Spitzlberger, Daina Chakma, Martina Anton, Christina M. Bebber, Gabriela M. Wiedemann, Toshitaka Nakamura, Gregor Ebert, Scott J. Dixon, Percy A. Knolle, Silvia von Karstedt, Nicolas Snaidero, Julia Esser-von Bieren, Marcus Conrad, Jan P. Böttcher
Institutions: Universitätsklinikum Tübingen, University of Tübingen, TUM Klinikum, Technical University of Munich, Helmholtz Munich, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, University Hospital Cologne, Stanford University, Hertie Institute for Clinical Brain Research, University of Lausanne, Tohoku University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $12,690
Awards: G173399175, G1740861664, G2074306890, G2532469498, G2591531669, Regulation of host defense by a helminthic glutamate dehydrogenase, G2810377833, G2899880, G3042149056, G3246393429, Schnelles ZweiPhotonen Mikroskop mit konfokaler Einheit für Intravital und Reflexionsbildgebung, Die Rolle von cDC1 Heterogenität für die Immunantwort gegen Krebs, G3864451752, SFB 1479: Onkogengetriebener Immun Escape (OncoEscape), G4454920794, Konsequenzen cPLA2αvermittelter Ferroptose Regulation im kleinzelligen Bronchialkarzinom, SFB 1403: Zelltod in Immunität, Entzündungen und Erkrankungen, G736310765, Die Rolle des ferroptotischen Zelltods für die Regulation der antitumor Immunität durch dendritische Zellen, G7647055356, G7949376443, Koordinationsfonds, TRR 355: Heterogenität und funktionelle Spezialisierung regulatorischer TZellen in unterschiedlichen Mikromilieus, Inverses kamerabasiertes WeitfeldFluoreszenzmikroskop, TRR 353: Regulation von Entscheidungen in Zelltodprozessen, Entwicklung eines Lipidbasierten FerroptoseBiomarkers für die Analyse neurodegenerativer Erkrankungen, Konfokales Laser Scanning Mikroskop mit Spektraler Detektion und FLIM, EXC 2180: Individualisierung von Tumortherapien durch molekulare Bildgebung und funktionelle Identifizierung therapeutischer Zielstrukturen (iFIT)
OpenAlex ID: W7236198088
